{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T09:15:17Z","timestamp":1648804517283},"reference-count":30,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,7,20]],"date-time":"2015-07-20T00:00:00Z","timestamp":1437350400000},"content-version":"vor","delay-in-days":19,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nefrolog\u00eda"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1016\/j.nefro.2015.06.013","type":"journal-article","created":{"date-parts":[[2015,7,22]],"date-time":"2015-07-22T19:22:28Z","timestamp":1437592948000},"page":"403-409","source":"Crossref","is-referenced-by-count":0,"title":["Administraci\u00f3n de calcimim\u00e9ticos posdi\u00e1lisis: igual efectividad, mejor tolerancia gastrointestinal"],"prefix":"10.1016","volume":"35","author":[{"given":"Vicent","family":"Esteve Simo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F\u00e1tima","family":"Moreno-Guzm\u00e1n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gemma","family":"Mart\u00ednez Calvo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miquel","family":"Fulquet Nicolas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monica","family":"Pou Potau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javier","family":"Macias-Toro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ver\u00f3nica","family":"Duarte-Gallego","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Saurina Sole","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manel","family":"Ram\u00edrez-de Arellano Serna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.nefro.2015.06.013_bib0155","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1016\/S0140-6736(14)60384-6","article-title":"Board of the EURECA-m Working Group of ERA-EDTA. Epidemiology, contributors to and clinical trials of mortality risk in chronic kidney failure","volume":"383","author":"Ortiz","year":"2014","journal-title":"Lancet."},{"key":"10.1016\/j.nefro.2015.06.013_bib0160","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1111\/j.1523-1755.2004.00894.x","article-title":"The burden of kidney disease: Improving global outcomes","volume":"66","author":"Eknoyan","year":"2004","journal-title":"Kidney Int"},{"key":"10.1016\/j.nefro.2015.06.013_bib0165","first-page":"243","article-title":"Consensus document for the detection and management of chronic kidney disease","volume":"34","author":"Mart\u00ednez-Castelao","year":"2014","journal-title":"Nefrolog\u00eda"},{"issue":"Suppl 99","key":"10.1016\/j.nefro.2015.06.013_bib0170","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1111\/j.1523-1755.2005.09904.x","article-title":"Epidemiology of chronic renal disease in the Galician population: Results of the pilot Spanish EPIRCE study","volume":"68","author":"Otero","year":"2005","journal-title":"Kidney Int"},{"key":"10.1016\/j.nefro.2015.06.013_bib0175","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1093\/fampra\/cmi026","article-title":"Identifying patients with chronic kidney disease from general practice computer records","volume":"22","author":"de Lusignan","year":"2005","journal-title":"Fam Pract"},{"key":"10.1016\/j.nefro.2015.06.013_bib0180","doi-asserted-by":"crossref","first-page":"87","DOI":"10.5414\/CN107285","article-title":"Cinacalcet for hemodialyzed patients with or without a high PTH level to control serum calcium and phosphorus: ECO (evaluation of cinacalcet HCl outcome) study","volume":"78","author":"Yokoyama","year":"2012","journal-title":"Clin Nephrol."},{"key":"10.1016\/j.nefro.2015.06.013_bib0185","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1093\/ndt\/gfs568","article-title":"Efficacy of cinacalcet with low-dose vitamin D in incident haemodialysis subjects with secondary hyperparathyroidism","volume":"28","author":"Ure\u00f1a-Torres","year":"2013","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nefro.2015.06.013_bib0190","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1038\/ki.2010.167","article-title":"Cinacalcet hydrochloride treatment significantly improves all-cause and cardiovascular survival in a large cohort of hemodialysis patients","volume":"78","author":"Block","year":"2010","journal-title":"Kidney Int."},{"key":"10.1016\/j.nefro.2015.06.013_bib0195","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1007\/s10157-012-0665-8","article-title":"Effects of cinacalcet on bone mineral density and bone markers in hemodialysis patients with secondary hyperparathyroidism","volume":"17","author":"Tsuruta","year":"2013","journal-title":"Clin Exp Nephrol."},{"key":"10.1016\/j.nefro.2015.06.013_bib0200","doi-asserted-by":"crossref","first-page":"e1001436","DOI":"10.1371\/journal.pmed.1001436","article-title":"Cinacalcet in patients with chronic kidney disease: A cumulative meta-analysis of randomized controlled trials","volume":"10","author":"Palmer","year":"2013","journal-title":"PLoS Med."},{"key":"10.1016\/j.nefro.2015.06.013_bib0205","doi-asserted-by":"crossref","DOI":"10.1159\/000319882","article-title":"Cinacalcet treatment for secondary hyperparathyroidism in dialysis patients: An observational study in routine clinical practice","volume":"118","author":"Bover","year":"2011","journal-title":"Nephron Clin Pract."},{"key":"10.1016\/j.nefro.2015.06.013_bib0210","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1681\/ASN.2004060512","article-title":"Cinacalcet HCl, an oral calcimimetic agent for the treatment of secondary hyperparathyroidism in hemodialysis and peritoneal dialysis: a randomized, double-blind, multicenter study","volume":"16","author":"Lindberg","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.nefro.2015.06.013_bib0215","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1124\/jpet.103.057273","article-title":"Pharmacodynamics of the type ii calcimimetic compound cinacalcet HCL","volume":"308","author":"Nemeth","year":"2004","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.nefro.2015.06.013_bib0220","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1159\/000350211","article-title":"Cinacalcet up regulates calcium-sensing receptors of parathyroid glands in hemodialysis patients","volume":"37","author":"Sumida","year":"2013","journal-title":"Am J Nephrol."},{"key":"10.1016\/j.nefro.2015.06.013_bib0225","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.2215\/CJN.02110310","article-title":"Cinacalcet effectively reduces parathyroid hormone secretion and gland volume regardless of pretreatment gland size in patients with secondary hyperparathyroidism","volume":"5","author":"Komaba","year":"2010","journal-title":"Clin J Am Soc Nephrol."},{"key":"10.1016\/j.nefro.2015.06.013_bib0230","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1053\/j.ajkd.2014.04.014","article-title":"Utilization and costs of medications associated with CKD mineral and bone disorder in dialysis patients enrolled in Medicare Part D","volume":"64","author":"Yusuf","year":"2014","journal-title":"Am J Kidney Dis."},{"key":"10.1016\/j.nefro.2015.06.013_bib0235","first-page":"145","article-title":"[The influence of side effects related to cinacalcet therapy on compliance in hemodialysis patients suffering from secondary hyperparathyroidism]","volume":"65","author":"Zwiech","year":"2012","journal-title":"WiadLek."},{"key":"10.1016\/j.nefro.2015.06.013_bib0240","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1159\/000350213","article-title":"Evaluating real-world use of cinacalcet and biochemical response to therapy in US hemodialysis patients","volume":"37","author":"Kilpatrick","year":"2013","journal-title":"Am J Nephrol."},{"key":"10.1016\/j.nefro.2015.06.013_bib0245","first-page":"448","article-title":"A novel dose regimen of cinacalcet in the treatment of severe hyperparathyroidism in hemodialysis patients","volume":"22","author":"Al Hilali","year":"2011","journal-title":"Saudi J Kidney Dis Transpl"},{"key":"10.1016\/j.nefro.2015.06.013_bib0250","first-page":"1516","article-title":"A prospective randomized pilot study on intermittent post-dialysis dosing of cinacalcet","volume":"350","author":"Haq","year":"2014","journal-title":"Int Urol Nephrol"},{"key":"10.1016\/j.nefro.2015.06.013_bib0255","unstructured":"Abouchacra S, Chaaban A, Haq N. A prospective Randomized trial on intermittent post-dialysis of cinacalcet: A solution to non-compliance. National Kidney Foundation 2010 Spring Clinical Meetings Abstracts. Adv Chronic Kidney Dis. 2010;17:206-07"},{"key":"10.1016\/j.nefro.2015.06.013_bib0260","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1056\/NEJMoa031633","article-title":"Cinacalcet for secondary hyperparatiroidism in patients receiving hemodialysis","volume":"350","author":"Block","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nefro.2015.06.013_bib0265","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1159\/000317935","article-title":"Cinacalcet-clinical and laboratory effectiveness, concomitant treatment patterns and treatment cost: Could we do better and how?","volume":"33","author":"Smr\u017eov\u00e1","year":"2010","journal-title":"Kidney Blood Press Res."},{"key":"10.1016\/j.nefro.2015.06.013_bib0270","first-page":"443","article-title":"Analysis of the efficacy and factors influencing the response of secondary hyperparathyroidism patients on hemodialysis to cinacalcet","volume":"30","author":"Segura Torres","year":"2010","journal-title":"Nefrolog\u00eda"},{"key":"10.1016\/j.nefro.2015.06.013_bib0275","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/j.1542-4758.2009.00397.x","article-title":"Assessment of adherence to cinacalcet by prescription refill rates in hemodialysis patients","volume":"14","author":"Gincherman","year":"2010","journal-title":"Hemodial Int."},{"key":"10.1016\/j.nefro.2015.06.013_bib0280","doi-asserted-by":"crossref","first-page":"303","DOI":"10.2165\/00003088-200948050-00002","article-title":"Clinical pharmacokinetic and pharmacodynamic profile of cinacalcet hydrochloride","volume":"48","author":"Padhi","year":"2009","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.nefro.2015.06.013_bib0285","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.2215\/CJN.00290109","article-title":"Pill Burden, adherence, hyperphosphatemia, and quality of life in maintenance dialysis patients","volume":"4","author":"Chiu","year":"2009","journal-title":"Clin J Am SocNephrol"},{"key":"10.1016\/j.nefro.2015.06.013_bib0290","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1056\/NEJMra050100","article-title":"Adherence to medication","volume":"353","author":"Osterberg","year":"2005","journal-title":"N Engl J Med."},{"key":"10.1016\/j.nefro.2015.06.013_bib0295","doi-asserted-by":"crossref","first-page":"798","DOI":"10.3111\/13696998.2011.627404","article-title":"Association of cinacalcet adherence and costs in patients on dialysis","volume":"14","author":"Lee","year":"2011","journal-title":"J Med Econ."},{"key":"10.1016\/j.nefro.2015.06.013_bib0300","doi-asserted-by":"crossref","first-page":"222","DOI":"10.4037\/ajcc2007.16.3.222","article-title":"Prevalence and consequences of non adherence to hemodialysis regimes","volume":"16","author":"Denhaerynck","year":"2007","journal-title":"Am J Crit Care."}],"container-title":["Nefrolog\u00eda"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0211699515000697?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0211699515000697?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,5]],"date-time":"2020-09-05T16:46:17Z","timestamp":1599324377000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0211699515000697"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,7]]}},"alternative-id":["S0211699515000697"],"URL":"https:\/\/doi.org\/10.1016\/j.nefro.2015.06.013","relation":{},"ISSN":["0211-6995"],"issn-type":[{"value":"0211-6995","type":"print"}],"subject":[],"published":{"date-parts":[[2015,7]]}}}